{ "@context": "https://schema.org", "@type": "FAQPage", "name": "CheckMyGLP Frequently Asked Questions", "url": "https://checkmyglp.com/#faq", "description": "Common questions about CheckMyGLP — eligibility, privacy, cost, safety, and process.", "last_updated": "2026-05-06", "categories": [ { "name": "About the tool", "faqs": [ { "@type": "Question", "name": "Is this a real eligibility check or just a quiz?", "acceptedAnswer": { "@type": "Answer", "text": "Both, in the right order. The calculator applies the actual FDA weight-management criteria a physician would use — BMI ≥30, or BMI ≥27 with a qualifying comorbidity. It is an educational screening, not a diagnosis. The final eligibility determination always rests with a licensed clinician." } }, { "@type": "Question", "name": "What does CheckMyGLP do?", "acceptedAnswer": { "@type": "Answer", "text": "CheckMyGLP is a free 90-second GLP-1 eligibility calculator. You answer six questions about height/weight, age, conditions, history, and goals. We return an instant color-coded verdict and email you a personalized AI-written readiness report (PDF attached) explaining what your result means, three honest cost paths, and a clear next step." } }, { "@type": "Question", "name": "How long does this take?", "acceptedAnswer": { "@type": "Answer", "text": "About 90 seconds for the calculator, instant on-screen results, and the report email arrives in under a minute. If you decide to start a physician evaluation, most can be completed within 24 hours through DrMedHealth." } }, { "@type": "Question", "name": "Do I have to give a credit card?", "acceptedAnswer": { "@type": "Answer", "text": "No. CheckMyGLP is free. We do not collect payment information at any step. We collect your name, email, and phone only after the calculator runs, so we can email you the personalized report." } }, { "@type": "Question", "name": "Will you tell me if I don't qualify?", "acceptedAnswer": { "@type": "Answer", "text": "Yes — directly. If your BMI is below the FDA threshold and you have no qualifying comorbidity, the report says so plainly and recommends non-pharmacological options. We don't push therapy on people who don't need it." } } ] }, { "name": "Privacy & data", "faqs": [ { "@type": "Question", "name": "Is my health information safe? What do you actually store?", "acceptedAnswer": { "@type": "Answer", "text": "Your medical answers — height, weight, conditions, medications, goals — are never written to our database. They live in memory only long enough to generate your personalized report and email it to you, then they are gone. The only things we keep are your name, email, and phone, so we can deliver the report and the follow-up guide series. We do not sell your data, do not share identifying information with third parties without your explicit consent, and a single unsubscribe click ends the relationship." } }, { "@type": "Question", "name": "Can I unsubscribe from the follow-up emails?", "acceptedAnswer": { "@type": "Answer", "text": "Yes — every email has a one-click unsubscribe link. There is no waiting period and no need to email support." } }, { "@type": "Question", "name": "Do you share my information with DrMedHealth or any other partner?", "acceptedAnswer": { "@type": "Answer", "text": "Not without your explicit consent. CheckMyGLP and DrMedHealth share a parent company (Public Health Solution LLC), but a handoff only happens when you click a CTA and start the DrMedHealth signup yourself. We don't pre-fill or pass your data." } } ] }, { "name": "Eligibility", "faqs": [ { "@type": "Question", "name": "What FDA criteria does the calculator use?", "acceptedAnswer": { "@type": "Answer", "text": "The same criteria used on the Wegovy and Zepbound prescribing labels — BMI ≥30 (any adult), or BMI ≥27 with at least one weight-related comorbidity. Qualifying comorbidities include type 2 diabetes, prediabetes, hypertension, sleep apnea, fatty liver, high cholesterol, cardiovascular disease, and PCOS." } }, { "@type": "Question", "name": "What if my BMI is below 30?", "acceptedAnswer": { "@type": "Answer", "text": "Many people qualify with BMI 27–29.9 if they also have a weight-related condition like prediabetes, hypertension, sleep apnea, fatty liver, or PCOS. The calculator accounts for this. If you are below all FDA thresholds, the report tells you honestly." } }, { "@type": "Question", "name": "Do I qualify for Ozempic?", "acceptedAnswer": { "@type": "Answer", "text": "Ozempic is FDA-approved for type 2 diabetes; weight-loss prescribing is off-label. CheckMyGLP applies the FDA weight-management criteria (the same ones Wegovy and Zepbound use), and the report will tell you whether you meet that bar — which is what most clinicians use when considering off-label Ozempic prescribing for weight." } }, { "@type": "Question", "name": "Do I qualify for Wegovy?", "acceptedAnswer": { "@type": "Answer", "text": "Wegovy's FDA label is for chronic weight management at BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity — the exact criteria CheckMyGLP screens. The free report will tell you your candidacy and explain which criterion applied (or didn't)." } }, { "@type": "Question", "name": "Do I qualify for Zepbound or Mounjaro?", "acceptedAnswer": { "@type": "Answer", "text": "Zepbound (tirzepatide) is FDA-approved for chronic weight management at BMI ≥30, or BMI ≥27 with comorbidity. Mounjaro is the same molecule but FDA-labeled for type 2 diabetes — weight-loss prescribing is off-label. CheckMyGLP screens against the FDA weight-management criteria that apply to Zepbound and tells you your candidacy." } } ] }, { "name": "GLP-1 medications", "faqs": [ { "@type": "Question", "name": "What does \"GLP-1 therapy\" actually mean?", "acceptedAnswer": { "@type": "Answer", "text": "GLP-1 medications (semaglutide, tirzepatide, sold as Wegovy, Zepbound, Ozempic, Mounjaro) mimic a hormone your body already produces after meals. They reduce appetite, slow gastric emptying, and improve insulin response. In trials they produced 15–22% average body weight loss over 14–18 months." } }, { "@type": "Question", "name": "What's the difference between compounded and FDA-approved GLP-1 medications?", "acceptedAnswer": { "@type": "Answer", "text": "FDA-approved brands (Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus) have undergone the FDA approval process and carry an FDA label. Compounded versions contain the same active ingredient but are prepared by licensed 503A/503B US pharmacies — they are NOT FDA-approved, but are legal under physician oversight. Compounded versions cost less ($150–$350/mo vs $899–$999/mo brand)." } }, { "@type": "Question", "name": "Is GLP-1 safe?", "acceptedAnswer": { "@type": "Answer", "text": "For appropriate candidates under physician supervision, yes — these medications have been studied extensively (STEP trials for semaglutide, SURMOUNT trials for tirzepatide, with thousands of participants). The most common side effects are GI: nausea, constipation, occasionally vomiting, especially during dose escalation. Real contraindications include personal/family history of medullary thyroid carcinoma, MEN2, and severe pancreatitis. A physician evaluation is how you know if it's safe for you specifically." } } ] }, { "name": "Cost", "faqs": [ { "@type": "Question", "name": "Do I need insurance?", "acceptedAnswer": { "@type": "Answer", "text": "No. Insurance can sometimes cover branded options like Wegovy or Zepbound when criteria are met, but cash-pay and licensed compounded options exist for $150–$650/month depending on the path. The report walks you through the realistic options for your situation." } }, { "@type": "Question", "name": "How much do GLP-1 medications cost?", "acceptedAnswer": { "@type": "Answer", "text": "It depends on the path. Insurance-covered Wegovy or Zepbound: typically $0–$25 copay when criteria are met. Cash-pay brand: Ozempic ~$899/mo, Wegovy ~$999/mo, Mounjaro ~$999/mo, Zepbound ~$1,000+/mo. Licensed compounded (NOT FDA-approved): semaglutide $150–$250/mo, tirzepatide $250–$350/mo. The free report calibrates which path is realistic for your specific situation." } } ] }, { "name": "Next steps", "faqs": [ { "@type": "Question", "name": "What happens after I get my report?", "acceptedAnswer": { "@type": "Answer", "text": "If you qualify and want to start treatment, the report includes a CTA to start a same-day physician evaluation through DrMedHealth (LegitScript-certified, all 50 states + DC + Guam). If you don't qualify, the report recommends non-pharmacological options. Either way, you'll receive a 7-touch educational email series over 14 days that you can unsubscribe from at any time." } }, { "@type": "Question", "name": "What is DrMedHealth and why do you mention it?", "acceptedAnswer": { "@type": "Answer", "text": "DrMedHealth is the LegitScript-certified GLP-1 telehealth platform we refer qualified candidates to. It's operated by the same parent company (Public Health Solution LLC) and offers 2–24 hour physician approval, 1-2 day free shipping, compounded semaglutide $199/mo, and FDA-approved brands. CheckMyGLP itself does NOT prescribe — DrMedHealth is the optional handoff for users who want to start treatment." } } ] } ] }